Francesc Valldeoriola
Overview
Explore the profile of Francesc Valldeoriola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
4435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Mena L, Pares G, Garrido A, Pilco-Janeta D, Fernandez M, Perez J, et al.
Mov Disord
. 2024 Dec;
PMID: 39711195
Background: α-Synuclein (SNCA) gene hypomethylation was reported in idiopathic Parkinson's disease (iPD). Based on a high clinical resemblance between iPD and leucine-rich repeat kinase 2 (LRRK2)-driven Parkinson's disease (L2PD), we...
2.
Roldan P, Mosteiro A, Arboix J, Asin D, Sanchez-Gomez A, Valldeoriola F, et al.
Stereotact Funct Neurosurg
. 2024 Nov;
:1-9.
PMID: 39602897
Introduction: Direct targeting in deep brain stimulation (DBS) has remarkably impacted the patient's experience throughout the surgery and the overall logistics of the procedure. When the individualised plan is co-registered...
3.
Ma Y, Farris C, Weber S, Schade S, Nguyen H, Perez-Soriano A, et al.
Lancet Neurol
. 2024 Nov;
23(12):1225-1237.
PMID: 39577923
Background: The pathological hallmarks of multiple system atrophy and Parkinson's disease are, respectively, misfolded-α-synuclein-laden glial cytoplasmic inclusions and Lewy bodies. CSF-soluble misfolded α-synuclein aggregates (seeds) are readily detected in people...
4.
Torres V, Perez-Montesino J, Fernandez-Santiago R, Fernandez M, Camara A, Compta Y, et al.
Ann Clin Transl Neurol
. 2024 Jul;
11(8):2222-2229.
PMID: 38952083
Impulse control disorders and their consequences display variability among individuals, indicating potential involvement of environmental and genetic factors. In this retrospective study, we analyzed a cohort of Parkinson's disease patients...
5.
Torres V, Del Giudice K, Roldan P, Rumia J, Munoz E, Camara A, et al.
NPJ Parkinsons Dis
. 2024 Jan;
10(1):29.
PMID: 38280901
Deep brain stimulation (DBS) is an effective treatment for patients with Parkinson's disease (PD). However, some patients may not respond optimally to clinical programming adjustments. Advances in DBS technology have...
6.
Roldan P, Mosteiro A, Valldeoriola F, Rumia J
Acta Neurochir (Wien)
. 2023 Jun;
165(8):2189-2195.
PMID: 37318635
Background: Traditionally, functional neurosurgery relied in stereotactic atlases and intraoperative micro-registration in awake patients for electrode placement in Parkinson's disease. Cumulative experience on target description, refinement of MRI, and advances...
7.
Alvarez-Mora M, Rodriguez-Revenga L, Jodar M, Potrony M, Sanchez A, Badenas C, et al.
Genes (Basel)
. 2023 Apr;
14(4).
PMID: 37107571
Neurological disorders (ND) are diseases that affect the brain and the central and autonomic nervous systems, such as neurodevelopmental disorders, cerebellar ataxias, Parkinson's disease, or epilepsies. Nowadays, recommendations of the...
8.
Valldeoriola F, Torres V
Eur Neuropsychopharmacol
. 2023 Mar;
72:4-5.
PMID: 36930990
No abstract available.
9.
Mena-Moreno T, Munguia L, Granero R, Lucas I, Sanchez-Gomez A, Camara A, et al.
JMIR Serious Games
. 2022 Sep;
10(3):e33858.
PMID: 36083621
Background: Impulse control disorders (ICDs) are commonly developed among patients who take dopamine agonist drugs as a treatment for Parkinson disease (PD). Gambling disorder and hypersexuality are more frequent in...
10.
Garrido A, Perez-Sisques L, Simonet C, Campoy-Campos G, Solana-Balaguer J, Martin-Flores N, et al.
Ann Neurol
. 2022 Aug;
92(5):888-894.
PMID: 35929078
The purpose of this study was to investigate whether differential phosphorylation states of blood markers can identify patients with LRRK2 Parkinson's disease (PD). We assessed phospho(P)-Ser-935-LRRK2 and P-Ser-473-AKT levels in...